
A study in the March issue of the Journal of Acquired Immune Deficiency Syndromes shows that the oral anabolic steroid oxandrolone may be effective in restoring body mass lost through HIV-related wasting syndrome, Reuters Health reports. Researchers at the University of California, San Francisco, treated 262 HIV-positive men who had lost 10% to 20% of their body mass with one of three doses of oxandrolone for 12 weeks or with a placebo. The men who took the steroid at any dosage gained weight and muscle tissue; the men in the placebo group showed no significant weight gain.
Steroid use did have adverse side effects, say the researchers, chief among them an increase in LDL—or “bad”—cholesterol and a drop in HDL—or “good”—cholesterol. Some of the study subjects who took the steroid also showed early signs of liver toxicity.
Current HIV-related wasting treatments include the use of nutritional supplements; a drug called megestrol acetate, which produces increases mostly in body fat; and human growth hormones like Serono’s Serostim, which cost thousands of dollars for a few weeks of treatment, reports Reuters Health. But the researchers say that because anabolic steroids produce increases in both muscle tissue and fat, the compounds could be useful for some HIV patients experiencing severe wasting, even in light of the potential adverse side effects.
HIV-related wasting is a relatively common condition among HIV patients, particularly those with advanced disease. Wasting puts HIVers at a higher risk of opportunistic infections and other HIV-related complications. (Advocate.com)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
Comments that do not concern specific articles in The Advocate or on Advocate.com will not be posted or published. See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.